期刊文献+

补肺平喘法对慢性阻塞性肺疾病肺功能改善的临床研究 被引量:3

Makes Up the Lung to Breathe Heavily Erenlymethod to the Chronic Obstructive Pulmonary Disease Improvement Clinical Research
下载PDF
导出
摘要 目的:观察补肺平喘法对慢性阻塞性肺疾病(COPD)缓解期患者的影响。方法:将55例COPD患者随机分为两组。治疗组35例,用补肺平喘法综合治疗。对照组20例,用常规治疗,观察临床症状、肺功能、血液流变学改善情况。结果:两组对临床症状、肺功能、血液流变学均有改善;治疗后比较,补肺平喘综合治疗法均优于对照组(P<0.05)。结论:补肺平喘综合治疗法对COPD缓解期患者具有防治作用,对减缓COPD进展速度有积极的现实意义。 Objective: The effect of the method of the utilization composite treatment(makes up lung to breathe heavily law to treat evenly) on patients suffered from COPD in catabasis was observed.Methods: 55 COPD patients were devided into two group s randomly,one was the treatment group which was treated with method of the composite treatment,and the other was the control group which routine treatment were performed.The clinical symptoms,such as frequency of catching cold,pulmonary function and hemorheology were observed.Results: Obvious improvement has occurred on clinical symptoms,pulmonary function and hemorheology in two groups.By comparison,the former group was better than the later(P0.05).Conclusion: Method of the composite treatment(makes up lung to breathe heavily evenly law) can be used in catabasis of COPD.
出处 《中华中医药学刊》 CAS 2010年第2期350-352,共3页 Chinese Archives of Traditional Chinese Medicine
基金 广东省中医药局科技项目(2060047)
关键词 慢性阻塞性肺疾病 综合疗法 chronic obstructive pulmonary disease the composite treatment
  • 相关文献

参考文献5

二级参考文献26

  • 1Saetta M,Turato G,Maestrelli P,et al.Cellular and structural bases of chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2001,163(6):1304-1309.
  • 2Calverley P,Pauwels R,Vestbo J,et al.Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease:a randomised controlled trial.Lancet,2003,361(9356):449-456.
  • 3Weersink EJ,Postma DS,Koeter GH,et al.Picumeterol:dissociation of improvement in lung function and reduction of airways hyperresponsiveness in asthmatics.Br J Clin Pharmacol,1997,43(2):169-176.
  • 4Rohatagi S,Arya V,Zech K,et al.Population pharmacokinetics and pharmacodynamics of ciclesonide.J Clin Pharmacol,2003,43(4):365-378.
  • 5Poole PJ,Black PN.Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease:systematic review.BMJ,2001,322(7297):1271-1274.
  • 6Kellerman DJ.P2Y(2) receptor agonists:a new class of medication targeted at improved mucociliary clearance.Chest,2002,121(5 Suppl):201S-205S.
  • 7Jackson AD.Airway goblet-cell mucus secretion.Trends Pharmacol Sci,2001,22(1):39-45.
  • 8Dent G.Current Opinion in Investigational.Drugs,2002,3(1):78-83.
  • 9Leung-Toung R,Li W,Tam TF,et al.Thiol-dependent enzymes and their inhibitors:a review.Curr Med Chem,2002,9(9):979-1002.
  • 10Minematsu N,Nakamura H,Tateno H,et al.Genetic polymorphism in matrix met alloproteinase-9 and pulmonary emphysema.Biochem Biophys Res Commun,2001,289(1):116-119.

共引文献5138

同被引文献20

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部